Communicable Disease Service

• Surveillance Criteria and Testing for Novel Coronavirus 2019 (COVID-19) (March 13, 2020)
• LINCS Message - Key Messages to Long Term Care Facilities for COVID-19 (March 4, 2020)
• Exposure Risk Categories  and Management Associated with International Travel or Contacts of Laboratory-Confirmed Cases (March 10, 2020)
• Monitoring and Movement Guidance for Managing Returning Travelers and/or Contacts of Confirmed Cases (March 10, 2020)
• LINCS Message - Update and Interim Guidance on Infection Prevention and Control for 2019 Novel Coronavirus (2019‐nCoV) (January 30, 2020)

• Instructions for Persons Who Test Positive for COVID-19 (March 25, 2020)
• Instructions for Persons Who Test Negative for COVID-19 )(March 25, 2020)

Community Education Training Webinar: For public health professionals

• COVID-2019 Community Education Train-the-Trainer Webinar (2/6/20). *The slides in this archived webinar were created in February for training purposes. As the situation evolves, the slides are updated and distributed to all trainees. Please e-mail Krista Reale for toolkit materials after viewing the training.

CDC Guidance

• Interim Guidance for Public Health Personnel Evaluating Persons Under Investigation (PUIs) and Asymptomatic Close Contacts of Confirmed Cases at Their Home or Non-Home Residential Settings (CDC)
• Interim Guidance for Healthcare Personnel with Potential Exposure in a Healthcare Setting to Patients with COVID-2019 (CDC)
• Interim Guidance for Emergency Medical Services Systems and 911 Public Safety Answering Points for COVID-2019 in the US (CDC)
• Healthcare Professional Preparedness Checklist for Transportation and Arrival of Patients Potentially Infected with COVID-2019 (CDC)
• Hospital Preparedness Checklist for Suspected of Confirmed COVID-2019 Patients (CDC)
• Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with COVID-2019 (CDC)
• Interim Infection Prevention and Control Recommendations for Patients with Known or Patients Under Investigation for COVID-2019 in a Healthcare Setting (CDC)
• EPA-registered Product Claims for Emerging Viral Pathogens (CDC)

Public Health and Environmental Laboratories (PHEL)

Technical Bulletin 20.1.4: Testing for COVID-19 PUIs

This poster is for use in healthcare settings.

• Arabic
• Chinese (simplified)
• English
• Gujarati
• Hindi
• Italian
• Korean
• Polish
• Portuguese (Brazilian)
• Spanish
• Tagalog